We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Quanta, SEC Agree to Settle COVID-19 Treatment Trial Fraud Charges
Quanta, SEC Agree to Settle COVID-19 Treatment Trial Fraud Charges
The Securities and Exchange Commission (SEC) announced Monday that Quanta and two of its top executives have agreed to settle fraud charges brought against the company, stemming from statements the company made related to a proposed COVID-19 treatment in 2021.